SAMD4A Activators
SAMD4A Activators encompass a range of chemical compounds that serve to enhance the functional activity of SAMD4A through indirect but specific mechanisms within cellular signaling pathways. Forskolin, through its elevation of intracellular cAMP levels, activates PKA, which can then phosphorylate substrates that alter the functional activity of SAMD4A, likely by changing its interactions with mRNA targets. Similarly, Epigallocatechin gallate, by inhibiting various kinases, can reduce competitive substrate phosphorylation, potentially allowing SAMD4A's role in mRNA degradation to become more pronounced within the cell. The lipid-derived messenger, Sphingosine-1-phosphate, acts through G-protein coupled receptors, potentially enhancing SAMD4A activity by modulating mRNA stability and degradation, which are central to SAMD4A's roles. LY294002 and Wortmannin, as PI3K inhibitors, influence AKT signaling and thereby could indirectly increase SAMD4A's activity by affecting the turnover of mRNA molecules that SAMD4A targets.
Additionally, PMA, by activating PKC, and Thapsigargin, by elevating intracellular calcium levels, can each modulate cellular conditions in a manner that may enhance SAMD4A's interaction with mRNA substrates. Staurosporine, despite its broad kinase inhibitory effects, may selectively activate SAMD4A pathways by alleviating inhibitory phosphorylation that could affect SAMD4A's function. The specific targeting of p38 MAPK by SB203580 and MEK by U0126 can lead to a shift in cellular signaling that favors SAMD4A's activity related to mRNA degradation. A23187, as a calcium ionophore, increases intracellular calcium that might activate calcium-dependent proteins and pathways intersecting with those regulated by SAMD4A, thus promoting SAMD4A's functional activity. Each activator, through its unique interaction with cellular signaling pathways, contributes to the collective enhancement of SAMD4A's role in post-transcriptional regulation of gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin acts by elevating cAMP levels, which in turn activates PKA. PKA phosphorylation can lead to changes in protein interactions and functions, thus Forskolin can indirectly enhance SAMD4A activity by modulating proteins that interact with or regulate SAMD4A within its specific signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
As a kinase inhibitor, Epigallocatechin gallate may decrease the phosphorylation of competing substrates, thereby potentially enhancing the functional activity of SAMD4A by reducing competitive signaling interference, allowing SAMD4A's role in mRNA degradation to be more prominent. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages G-protein coupled receptors and can initiate signaling cascades that modulate mRNA stability and degradation, processes that are central to SAMD4A's function, thus potentially enhancing SAMD4A activity by altering the availability or stability of its targets. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter AKT signaling, which is involved in mRNA turnover. As SAMD4A is implicated in mRNA degradation, LY294002 could indirectly enhance SAMD4A's functional activity by affecting the stability or translation of mRNAs that SAMD4A targets. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can modulate numerous pathways, including those involved in mRNA processing. By activating PKC, PMA may enhance SAMD4A activity through downstream signaling effects that influence SAMD4A's interactions with mRNA substrates. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels, which can activate calcium-dependent signaling pathways. These pathways can affect mRNA stability and degradation, potentially enhancing the activity of SAMD4A by influencing the cellular milieu in which SAMD4A operates. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, which may lead to selective activation of SAMD4A pathways by inhibiting kinases that negatively regulate SAMD4A's function in mRNA processing. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which can shift signaling pathways towards those that favor SAMD4A's role in mRNA degradation. By inhibiting p38 MAPK, SB203580 could enhance SAMD4A's functional activity by modulating the cellular processes that control mRNA stability. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may reduce competition from tyrosine kinase signaling. This reduction could enhance SAMD4A's activity by allowing its pathway to be more active in the regulation of mRNA degradation and processing. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, which could enhance SAMD4A's activity by activating calcium-dependent signaling pathways that intersect with SAMD4A's role in mRNA turnover. | ||||||